We describe a critically ill COVID-19 patient with a mild haemophilia A, morbid obesity and acute respiratory distress syndrome (ARDS) who required prolonged FVIII substitution due to intensive treatment of SARS-CoV-2 infection and who successfully recovered from the disease. The gene discussed is F8; the disease is hemophilia A.